The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Utilization patterns of abiraterone acetate before and after chemotherapy in patients with metastatic castration-resistant prostate cancer in the Veterans Health Administration System.
Diana I. Brixner
Employment or Leadership Position - University of Utah
Consultant or Advisory Role - Abbott Laboratories; Bristol-Myers Squibb
Research Funding - University of Utah
Ravinder Dhawan
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Raymond Miao
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Jennifer Sung
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Li Wang
Consultant or Advisory Role - STATinMED Research is a paid consultant for Sanofi.
Onur Baser
Consultant or Advisory Role - STATinMED Research is a paid consultant for Sanofi.
Jyotsna Mehta
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi